Holen Sie sich die Stockscreener-App
330.17
2.95%
9.45
Handel nachbörslich:
332.50
2.33
+0.71%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Amgen Inc Aktie (AMGN) Neueste Nachrichten
Amgen Paints Pipeline Dark Blue In Acquisition of Small Molecule Developer - Citeline News & Insights
Amgen’s Own High Court Loss Cited in Pushback to Evenity Claims - Bloomberg Law News
Amgen swoops on UK cancer biotech in deal worth up to $840mn - Financial Times
Amgen Agrees to Buy Dark Blue Therapeutics in Up to $840 Million Deal - TradingView — Track All Markets
Amgen buys protein-degrading startup Dark Blue for up to $840M - BioPharma Dive
$840 million Dark Blue buy hands Amgen AML drug - The Pharma Letter
Amgen buys UK biotech Dark Blue Therapeutics for up to $840m - Sharecast.com
Amgen to buy blood cancer biotech Dark Blue Therapeutics in $840M deal - Axios
Amgen acquires Dark Blue Therapeutics, bolstering oncology pipeline - marketscreener.com
Amgen adds preclinical cancer asset via $840M deal for Dark Blue Therapeutics - FirstWord Pharma
Amgen Buys Dark Blue Therapeutics in Deal Worth Up to $840 Million - marketscreener.com
Amgen (AMGN) Acquires Dark Blue Therapeutics for $840 Million - GuruFocus
Amgen acquires Dark Blue Therapeutics for up to $840 million - Investing.com
Dark Blue Therapeutics acquired by Amgen for up to $840 million - marketscreener.com
Amgen (AMGN) Expands Oncology Portfolio with Acquisition of Dark Blue Therapeutics - GuruFocus
Amgen acquires Dark Blue Therapeutics for up to $840 million By Investing.com - Investing.com Canada
Amgen Acquires Privately-held Dark Blue Therapeutics In $840 Mln Deal - Nasdaq
Zenas’s Obexelimab Meets Phase III Endpoint In IgG4-RD But Trails Amgen Rival - Citeline News & Insights
AMGEN ACQUIRES DARK BLUE THERAPEUTICS, BOLSTERING ONCOLOGY PIPELINE - PR Newswire
Amgen Buys Cancer Drug Developer Dark Blue in $840 Million Deal - Bloomberg.com
Zenas Plummets After Late-Stage Data Fall Short of Amgen in Inflammatory Disease - BioSpace
What to Expect From Amgen's Q4 2025 Earnings Report - Barchart.com
Commonwealth Equity Services LLC Has $105.58 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen (AMGN) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
Zenas Bio Inflammation Drug Meets Phase 3 Goals, But Is It Enough to Compete With Amgen? - MedCity News
D.A. Davidson & CO. Purchases 6,222 Shares of Amgen Inc. $AMGN - MarketBeat
Greenspring Advisors LLC Makes New $1.69 Million Investment in Amgen Inc. $AMGN - MarketBeat
AbbVie Challenges Amgen With $100M Upfront for Trispecific Lung Cancer Drug - BioSpace
Beat the Market the Zacks Way: LATAM, General Motors, Amgen in Focus - Yahoo Finance
Railway Pension Investments Ltd Has $27.18 Million Position in Amgen Inc. $AMGN - MarketBeat
With 80% Ownership, Amgen Inc. (NASDAQ:AMGN) Boasts of Strong Institutional Backing - 富途牛牛
Asset Management One Co. Ltd. Buys 9,753 Shares of Amgen Inc. $AMGN - MarketBeat
Davis Capital Management Makes New Investment in Amgen Inc. $AMGN - MarketBeat
Allspring Global Investments Holdings LLC Boosts Holdings in Amgen Inc. $AMGN - MarketBeat
Dividend Watch: What sentiment indicators say about Amgen Inc stockForecast Cut & Real-Time Sentiment Analysis - moha.gov.vn
Amgen Inc. Stock Shock: Is This ‘Boring’ Biotech Suddenly a Must?Buy Power Play? - AD HOC NEWS
Amgen Inc. $AMGN Shares Bought by Verity & Verity LLC - MarketBeat
SteelPeak Wealth LLC Sells 52,953 Shares of Amgen Inc. $AMGN - MarketBeat
Mattern Capital Management LLC Buys 4,411 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Miracle Mile Advisors LLC - MarketBeat
Pullback Watch: Is Amgen Inc AMG0 stock worth holding before Fed meetingWeekly Trend Recap & Stock Market Timing Techniques - moha.gov.vn
Braun Stacey Associates Inc. Has $1.27 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Acquired by Hofer & Associates. Inc - MarketBeat
VIRGINIA RETIREMENT SYSTEMS ET Al Decreases Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Bought by Ascent Group LLC - MarketBeat
Amgen Inc (TSX:AMGN) Stock News, Headlines & Updates - GuruFocus
Amgen Inc. $AMGN Shares Acquired by Calamos Wealth Management LLC - MarketBeat
Boston Trust Walden Corp Lowers Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen (AMGN): Buy, Sell, or Hold Post Q3 Earnings? - TradingView — Track All Markets
Strong Results and Pipeline Momentum Power Amgen's (AMGN) 2025 Rally - Finviz
Strong Results and Pipeline Momentum Power Amgen’s (AMGN) 2025 Rally - Insider Monkey
Amgen stock dips as Lumakras combo trial ends; MariTide data now the next watch - ts2.tech
Can Amgen's MariTide Take on Leaders in the Obesity Space? - The Globe and Mail
Argus Forecasts Strong Price Appreciation for Amgen (NASDAQ:AMGN) Stock - MarketBeat
Argus Adjusts Price Target on Amgen to $360 From $310, Maintains Buy Rating - marketscreener.com
Diversified Trust Co Has $12.05 Million Stock Position in Amgen Inc. $AMGN - MarketBeat
The Truth About Amgen Inc.: Is This Biotech Giant the Next Big Money Gamechanger? - AD HOC NEWS
Amgen Inc.: How a Biotech Veteran Is Rebuilding Its Flagship Pipeline - AD HOC NEWS
Amgen stock slips to $330 as year-end pullback hits Wall Street; Fed minutes and MariTide updates in focus - ts2.tech
Strong results and pipeline momentum power Amgen’s (AMGN) 2025 rally - MSN
Verastem ends trial of Avmapki Fakzynja combo with Amgen's Lumakras in NSCLC - Seeking Alpha
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Amgen Inc. $AMGN Shares Acquired by SS&H Financial Advisors Inc. - MarketBeat
Amgen Inc. Stock (AMGN) Opinions on 2025 Revenue Guidance and Drug Sales - Quiver Quantitative
Amgen Inc. $AMGN Shares Sold by Meyer Handelman Co. - MarketBeat
Carnegie Investment Counsel Has $30.27 Million Stake in Amgen Inc. $AMGN - MarketBeat
Can Amgen Sustain Its Rally In 2026 (NASDAQ:AMGN) - Seeking Alpha
Check out Amgen's stock price (AMGN-CA) in real time - CNBC
Amgen Inc. $AMGN Stake Reduced by Pacer Advisors Inc. - MarketBeat
2.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):